Larvol Delta - Safety-and-Immune-Responses-After-Vaccination-With-Two-Investigational-RNAbased-Vaccines-Against-Tuberculosis-in-Healthy-Volunteers

BNT164a1 - BioNTech

BNT164b1 - BioNTech

http://clinicaltrials.gov/ct2/show/NCT05537038

Oct 24, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next